181 related articles for article (PubMed ID: 11641264)
1. A molecular mechanism for genetic warfarin resistance in the rat.
Wallin R; Hutson SM; Cain D; Sweatt A; Sane DC
FASEB J; 2001 Nov; 15(13):2542-4. PubMed ID: 11641264
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of calumenin on the vitamin K-dependent gamma-carboxylation system. Characterization of the system in normal and warfarin-resistant rats.
Wajih N; Sane DC; Hutson SM; Wallin R
J Biol Chem; 2004 Jun; 279(24):25276-83. PubMed ID: 15075329
[TBL] [Abstract][Full Text] [Related]
3. Warfarin resistance is associated with a protein component of the vitamin K 2,3-epoxide reductase enzyme complex in rat liver.
Cain D; Hutson SM; Wallin R
Thromb Haemost; 1998 Jul; 80(1):128-33. PubMed ID: 9684798
[TBL] [Abstract][Full Text] [Related]
4. Warfarin resistance in a French strain of rats.
Lasseur R; Longin-Sauvageon C; Videmann B; Billeret M; Berny P; Benoit E
J Biochem Mol Toxicol; 2005; 19(6):379-85. PubMed ID: 16421894
[TBL] [Abstract][Full Text] [Related]
5. Mutations in VKORC1 cause warfarin resistance and multiple coagulation factor deficiency type 2.
Rost S; Fregin A; Ivaskevicius V; Conzelmann E; Hörtnagel K; Pelz HJ; Lappegard K; Seifried E; Scharrer I; Tuddenham EG; Müller CR; Strom TM; Oldenburg J
Nature; 2004 Feb; 427(6974):537-41. PubMed ID: 14765194
[TBL] [Abstract][Full Text] [Related]
6. Characterization of bromadiolone resistance in a danish strain of Norway rats, Rattus norvegicus, by hepatic gene expression profiling of genes involved in vitamin K-dependent gamma-carboxylation.
Markussen MD; Heiberg AC; Fredholm M; Kristensen M
J Biochem Mol Toxicol; 2007; 21(6):373-81. PubMed ID: 17994578
[TBL] [Abstract][Full Text] [Related]
7. Identification of the gene for vitamin K epoxide reductase.
Li T; Chang CY; Jin DY; Lin PJ; Khvorova A; Stafford DW
Nature; 2004 Feb; 427(6974):541-4. PubMed ID: 14765195
[TBL] [Abstract][Full Text] [Related]
8. VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors.
Wallin R; Wajih N; Hutson SM
Vitam Horm; 2008; 78():227-46. PubMed ID: 18374197
[TBL] [Abstract][Full Text] [Related]
9. VKORC1L1, an enzyme rescuing the vitamin K 2,3-epoxide reductase activity in some extrahepatic tissues during anticoagulation therapy.
Hammed A; Matagrin B; Spohn G; Prouillac C; Benoit E; Lattard V
J Biol Chem; 2013 Oct; 288(40):28733-42. PubMed ID: 23928358
[TBL] [Abstract][Full Text] [Related]
10. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane.
Cain D; Hutson SM; Wallin R
J Biol Chem; 1997 Nov; 272(46):29068-75. PubMed ID: 9360981
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation in VKORC1 and its effect on enzymatic activity in Japanese warfarin-resistant rats.
Tanaka KD; Kawai YK; Ikenaka Y; Harunari T; Tanikawa T; Fujita S; Ishizuka M
J Vet Med Sci; 2013 Feb; 75(2):135-9. PubMed ID: 23018795
[TBL] [Abstract][Full Text] [Related]
12. Structure and function of vitamin K epoxide reductase.
Tie JK; Stafford DW
Vitam Horm; 2008; 78():103-30. PubMed ID: 18374192
[TBL] [Abstract][Full Text] [Related]
13. Warfarin and the vitamin K-dependent gamma-carboxylation system.
Wallin R; Hutson SM
Trends Mol Med; 2004 Jul; 10(7):299-302. PubMed ID: 15242675
[TBL] [Abstract][Full Text] [Related]
14. Puerarin offsets the anticoagulation effect of warfarin in rats by inducing rCyps, upregulating vitamin K epoxide reductase and inhibiting thrombomodulin.
Ge B; Zhang Z; Lam TT; Zuo Z
Biopharm Drug Dispos; 2017 Jan; 38(1):33-49. PubMed ID: 27925234
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of the coumarin anticoagulant targeted vitamin K epoxide reduction system. Study of kinetic parameters in susceptible and resistant mice (Mus musculus domesticus).
Lasseur R; Grandemange A; Longin-Sauvageon C; Berny P; Benoit E
J Biochem Mol Toxicol; 2006; 20(5):221-9. PubMed ID: 17009238
[TBL] [Abstract][Full Text] [Related]
16. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
Wilson CR; Sauer JM; Carlson GP; Wallin R; Ward MP; Hooser SB
Toxicology; 2003 Aug; 189(3):191-8. PubMed ID: 12832152
[TBL] [Abstract][Full Text] [Related]
17. The genetic basis of resistance to anticoagulants in rodents.
Pelz HJ; Rost S; Hünerberg M; Fregin A; Heiberg AC; Baert K; MacNicoll AD; Prescott CV; Walker AS; Oldenburg J; Müller CR
Genetics; 2005 Aug; 170(4):1839-47. PubMed ID: 15879509
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
Hildebrandt EF; Suttie JW
Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339
[TBL] [Abstract][Full Text] [Related]
19. Engineering of a recombinant vitamin K-dependent gamma-carboxylation system with enhanced gamma-carboxyglutamic acid forming capacity: evidence for a functional CXXC redox center in the system.
Wajih N; Sane DC; Hutson SM; Wallin R
J Biol Chem; 2005 Mar; 280(11):10540-7. PubMed ID: 15640149
[TBL] [Abstract][Full Text] [Related]
20. Vitamin K-dependent carboxylation and vitamin K metabolism in liver. Effects of warfarin.
Wallin R; Martin LF
J Clin Invest; 1985 Nov; 76(5):1879-84. PubMed ID: 3932474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
